HOME >> MEDICINE >> NEWS
Aspirin use during pregnancy could reduce risk of pre-eclampsia

Women who receive aspirin or other antiplatelet drugs during pregnancy are at lower risk of pre-eclampsia, conclude authors of a study published early Online and in an upcoming edition of The Lancet. But an accompanying comment says that potential risks of aspirin use must be considered by individual mothers before embarking on treatment.

Pre-eclampsia is a multisystem disorder of pregnancy that is usually associated with high blood pressure and proteinuria (excess of serum proteins in the urine).

Dr Lisa Askie, University of Sydney, Australia, with funding from the Australian National Health and Medical Research Council, along with colleagues from Australia and the UK, formed the Perinatal Antiplatelet Review of International Studies (PARIS) collaborative group and did a meta-analysis (a study which combines the results of previous trials) on more than 32,000 women and their babies.

They found that the risks of developing pre-eclampsia, of delivering before 34 weeks and of having a pregnancy with a severe adverse outcome all fell by 10% in those women taking aspirin or other antiplatelet drugs.

Aspirin was found to have no significant effect on the risk of death of the fetus or baby, having a small for gestational age infant, or bleeding events for either the women or their babies. No particular subgroup of women was substantially more or less likely to benefit from aspirin than any other.

The cause of pre-eclampsia remains unclear, although it is known that complications in the maternal spiral arteries in early pregnancy can lead to irregular blood flow to the placenta, causing blood clots in and death to placental tissue. This can lead to activation of the platelets and clotting system and an imbalance between hormones which promote and slow blood flow. Antiplatelet agents such as aspirin are thought to prevent pre-eclampsia by redressing this balance.

The authors conclude: "Our data show that antipla
'"/>

Contact: Dr. Lisa Askie
laskie@ctc.usyd.edu.au
61-423-330-089
Lancet
16-May-2007


Page: 1 2

Related medicine news :

1. Aspirin reduces esophageal-cancer risk in people with most-aggressive form of Barretts esophagus
2. Aspirin saves lives of cancer patients suffering heart attacks, despite fears of bleeding
3. Aspirin and other NSAIDs may not reduce the risk of colorectal cancer in long-term smokers
4. Aspirin + dipyridamole better than aspirin alone to prevent circulatory problems after minor stroke
5. Aspirin shows promise in combating a common, antibiotic-induced hearing loss
6. Aspirin to prevent heart disease is beneficial in a wider range of men
7. Aspirin therapy may be safe for some survivors of brain hemorrhage
8. Aspirin reduces the risk of cardiovascular events, though effects differ between men and women
9. Aspirin reduces cardiovascular risks in men and women -- but differently
10. Aspirin may help the heart, but one in ten patients will also develop an ulcer, new research shows
11. Aspirin can cut death rates in postmenopausal women with cardiovascular disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... September 22, 2017 , ... Ecocor , ... Richard Pedranti Architect (RPA), a full-service architecture firm focusing on sustainable design, ... Line of Model Homes . Independently, Ecocor and RPA have extensive experience with ...
(Date:9/22/2017)... ... , ... Pullano Law Offices, a Chicago personal injury law firm, is pleased ... serve as President of the North Suburban Bar Association for 2017-2018. Mr. Pullano was ... the NSBA at the North Shore Country Club in Glenview, IL, on September 13, ...
(Date:9/22/2017)... Francisco, CA (PRWEB) , ... September 22, 2017 ... ... way to help you brush more effectively even on the go. Their electric ... like gingivitis and gum inflammation, with UV sanitizing technology. Combining leading edge Enke ...
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... ... Lyme and other tick-borne diseases through research, education and awareness, today announced the ... A noted immunologist and microbiologist, Dr. Sellati has more than 20 years of ...
(Date:9/21/2017)... ... September 21, 2017 , ... The ... Behavioral Health Services for professionals in the addiction treatment industry entitled: Special ... , Insurance companies and state and federal governments are increasingly scrutinizing the ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
(Date:9/7/2017)... Sept. 7, 2017  For nearly two decades, New Life Agency has ... Reproduction Insurance industry. Today, New Life Agency announces a powerful three-way partnership ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/6/2017)... -- Robert G. Szewc, M.D., is recognized by Continental Who,s ... his contributions to the Medical field.      ... practice of Kidney and Hypertension Specialists, which specializes in ... He has worked in this position since 2002, and ... as expertise in kidneys, hypertension, chronic disease and anemia, ...
Breaking Medicine Technology:
Cached News: